Prolyl hydroxylase 3 involvement in lung cancer progression under hypoxic conditions: association with hypoxia-inducible factor-1 α and pyruvate kinase M2.
Conclusions: PHD3 is involved in lung cancer progression, and might be a promising therapeutic target for cancers.
PMID: 31656668 [PubMed]
Source: Journal of Thoracic Disease - Category: Respiratory Medicine Tags: J Thorac Dis Source Type: research